Cleared Traditional

K980130 - ABL700 SERIES BLOOD GAS

K980130 is an FDA 510(k) clearance for ABL700 SERIES BLOOD GAS, manufactured by Radiometer America, Inc.. The device is a Class 2 Chemistry device with product code CHL cleared through the Traditional 510(k) pathway after a 26-day FDA review.

K980130 · Radiometer America, Inc. · Chemistry device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Feb 1998
Decision
26d
Days
Class 2
Risk

K980130 is an FDA 510(k) clearance for the ABL700 SERIES BLOOD GAS , CO-OXIMETRY, ELECTROLYTE & METABOLITE SYSTEM. Classified as Electrode Measurement, Blood-gases (pco2, Po2) And Blood Ph (product code CHL), Class II - Special Controls.

Submitted by Radiometer America, Inc. (Westlake, US). The FDA issued a Cleared decision on February 9, 1998 after a review of 26 days - a notably fast clearance cycle.

This device falls under the Chemistry FDA review panel, regulated under 21 CFR 862.1120 - the FDA in vitro diagnostics and chemistry framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Radiometer America, Inc. devices

FDA 510(k) Submission Details - K980130

510(k) Number K980130 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received January 14, 1998
Decision Date February 09, 1998
Days to Decision 26 days
Submission Type Traditional
Review Panel Chemistry (CH)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
62d faster than avg
Panel avg: 88d · This submission: 26d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

CHL Device Classification - Class 2, Special Controls

Product Code CHL Electrode Measurement, Blood-gases (pco2, Po2) And Blood Ph
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 862.1120
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Chemistry devices follow this clearance model.

Regulatory Peers - CHL Electrode Measurement, Blood-gases (pco2, Po2) And Blood Ph

All 151
Devices cleared under the same product code (CHL) and FDA review panel - the closest regulatory comparables to K980130.
NPT7 SERIES PH/BLOOD GAS AND CO-OXIMETRY SYSTEM
K982928 · Radiometer America, Inc. · Jan 1999
MODIFICATION TO STAT PROFILE PHOX BLOOD GAS ANALYZER (K980991)
K982277 · Nova Biomedical Corp. · Jul 1998
NOVA STAT PROFILE PHOX BLOOD GAS ANALYZER
K980991 · Nova Biomedical Corp. · Apr 1998
EASYBLOOD GAS ANALYZER
K974526 · Medica Corp. · Feb 1998
ABL555 BLOOD GAS, ELECTROLYTE & METABOLITE SYSTEM
K973367 · Radiometer America, Inc. · Oct 1997
STAT PROFILE ULTRA M ANALYZER
K970710 · Nova Biomedical Corp. · May 1997